Related:
Serving nearly 400 medical device, pharmaceutical and biotech companies
Baker Tilly works with private and public life sciences companies, private equity firms and portfolio companies to help meet company goals in all stages of the lifecycle – from launch to growth to maturity to exit. Our work with stakeholders across the industry spectrum, including health plans, providers and life sciences companies, provides us with a 360-degree industry view to address your needs.
Life sciences companies develop new and enhance existing technologies to better patients’ lives. Baker Tilly provides solutions to the challenges and opportunities inherent in each stage of a company’s lifecycle, helping facilitate better patient health outcomes and providing our clients with peace of mind regarding their financial operations.
Baker Tilly’s comprehensive industry knowledge, deep experience and strategic relationships can help life sciences companies grow their business. Our team provides actionable ideas and solutions drawn from our work with hundreds of life sciences companies nationwide, including medical device, pharmaceutical and biotech companies. Team members have been published in multiple peer-reviewed publications and medical journals, demonstrating their expertise in helping companies achieve their objectives.
Using patient data, clinical utility/economic studies and relationships with providers and health plans, we develop value propositions for companies’ technology that demonstrate a compelling story to insurance companies and providers’ customers.
By helping establish a solid foundation of risk assessment and mitigation strategies, tax minimization approaches and effective implementation of new financial regulations, we help companies attain the financial health that is important to investors and lenders.
The capital required for funding ongoing operations and new product development is available through various sources. Utilizing our relationships with and understanding of these sources can help companies achieve the desired financing outcome.
Life sciences industry leader Mike McKee and healthcare and life sciences consulting partner David Gregory share how Baker Tilly is making a difference for life sciences companies during all stages of their lifecycle, including helping companies address reimbursement challenges, grow their presence internationally and understand capital requirements.
Baker Tilly gives you all of the expertise and technical comfort you get from a Big Four firm, but they are more responsive and flexible to work with. The team selected for our engagement has significant manufacturing expertise that meets our needs. I don’t have to teach them about our business.Ed Meyer, CFO, NPI Medical
See how Baker Tilly helped a medical device company better articulate the value proposition of a new technology for hospitals that could be a break-through in breast cancer detection and management.